Rebate walls are exclusionary contracting practices that a drug manufacturer deploys to limit the ability of rivals from gaining preferred access to the formulary, or any access at all. As such, they limit the uptake of biosimilars, (specialty) generics, and branded competitors.
Rebate Walls Stifle Prescription Drug Competition
